Liver metastases of unknown primary: malignant melanoma
- PMID: 25374724
- PMCID: PMC4207601
- DOI: 10.1155/2014/131708
Liver metastases of unknown primary: malignant melanoma
Abstract
According to the National Cancer Institute's (NCI) data, the increase in the number of patients diagnosed with malignant melanoma was found to be at a higher rate than the current increase in all other types of cancer (Jemal et al., 2008). Early diagnosis, appropriate surgical treatment, and chemotherapy have positive impacts on the course of the disease but despite these developments on the treatment, current prognosis of metastatic malignant melanoma prognosis is still extremely poor. Life expectancy in patients with metastatic disease is between 2 and 8 months. The 5-year disease-free survival rate is identified in only 5% of the patients (Leong, 2003) (Kirkwood et al., 1996). In this study, we try to report a patient with metastatic malignant melanoma and give recent informations about the liver metastases of malignant melanoma.
Figures


References
-
- Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA: A Cancer Journal for Clinicians. 2008;58(2):71–96. - PubMed
-
- Leong SPL. Selective sentinel lymphadenectomy for malignant melanoma. Surgical Clinics of North America. 2003;83(1):157–185. - PubMed
-
- Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group trial EST 1684. Journal of Clinical Oncology. 1996;14(1):7–17. - PubMed
-
- Schuchter LM, Green R, Fraker D. Primary and metastatic diseases in malignant melanoma of the gastrointestinal tract. Current Opinion in Oncology. 2000;12(2):181–185. - PubMed
-
- Patel JK, Didolkar MS, Pickren JW, Moore RH. Metastatic pattern of malignant melanoma: a study of 216 autopsy cases. The American Journal of Surgery. 1978;135(6):807–810. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources